Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model

I. Leprán, Piero Pollesello, Szilvia Vajda, A. Varró, J. Papp

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The preconditioning effects of levosimendan were investigated on ischemia-reperfusion induced morphological and functional cardiac damage. Langendorff-perfused rabbit hearts were reserved as controls or subjected either to global myocardial ischemic preconditioning or to perfusion with levosimendan (0.1 μmol/l) for two 5-minute cycles. After a washout period, all hearts were then subjected to 30 minutes of global ischemia and 120 minutes of drug-free reperfusion. Intraventricular pressure and coronary flow were measured, and infarct size determined after nitroblue-tetrazolium staining on completion of the experiments. Levosimendan pretreatment resulted in a significantly smaller elevation from the preischemic level in left ventricular end-diastolic pressure during reperfusion (37 ± 17 mm Hg) compared with controls (56 ± 14 mm Hg) and ischemia-preconditioned hearts (53 ± 34 mm Hg). The left ventricular developed pressure-representing the functional recovery of the heart after ischemia-that was significantly improved by levosimendan pretreatment (38 ± 6% vs 16 ± 5% in controls, P <0.05). In addition, contractility and relaxability parameters (+dP/dt and -dP/dt, respectively) were better preserved in the levosimendan hearts. The volume of infarcted myocardium after global ischemia-reperfusion was significantly (P <0.05) decreased by both ischemic preconditioning (38 ± 2%) or levosimendan pretreatment (45 ± 2%) versus controls (52 ± 2%). The results of this study suggest that levosimendan pretreatment is capable of decreasing infarct size in an ischemia-reperfusion model and improving recovery of cardiac function following ex vivo global ischemia.

Original languageEnglish
Pages (from-to)148-152
Number of pages5
JournalJournal of Cardiovascular Pharmacology
Volume48
Issue number4
DOIs
Publication statusPublished - Oct 2006

Fingerprint

Reperfusion
Ischemia
Rabbits
Ventricular Pressure
Myocardial Ischemic Preconditioning
Nitroblue Tetrazolium
Ischemic Preconditioning
Recovery of Function
simendan
Myocardium
Perfusion
Staining and Labeling
Blood Pressure
Pharmaceutical Preparations

Keywords

  • Cardiac mechanical activity
  • Infarct size
  • Ischemia
  • Levosimendan
  • Preconditioning

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model. / Leprán, I.; Pollesello, Piero; Vajda, Szilvia; Varró, A.; Papp, J.

In: Journal of Cardiovascular Pharmacology, Vol. 48, No. 4, 10.2006, p. 148-152.

Research output: Contribution to journalArticle

@article{d46bbce97f3c4f4c98a0480b8d7d437d,
title = "Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model",
abstract = "The preconditioning effects of levosimendan were investigated on ischemia-reperfusion induced morphological and functional cardiac damage. Langendorff-perfused rabbit hearts were reserved as controls or subjected either to global myocardial ischemic preconditioning or to perfusion with levosimendan (0.1 μmol/l) for two 5-minute cycles. After a washout period, all hearts were then subjected to 30 minutes of global ischemia and 120 minutes of drug-free reperfusion. Intraventricular pressure and coronary flow were measured, and infarct size determined after nitroblue-tetrazolium staining on completion of the experiments. Levosimendan pretreatment resulted in a significantly smaller elevation from the preischemic level in left ventricular end-diastolic pressure during reperfusion (37 ± 17 mm Hg) compared with controls (56 ± 14 mm Hg) and ischemia-preconditioned hearts (53 ± 34 mm Hg). The left ventricular developed pressure-representing the functional recovery of the heart after ischemia-that was significantly improved by levosimendan pretreatment (38 ± 6{\%} vs 16 ± 5{\%} in controls, P <0.05). In addition, contractility and relaxability parameters (+dP/dt and -dP/dt, respectively) were better preserved in the levosimendan hearts. The volume of infarcted myocardium after global ischemia-reperfusion was significantly (P <0.05) decreased by both ischemic preconditioning (38 ± 2{\%}) or levosimendan pretreatment (45 ± 2{\%}) versus controls (52 ± 2{\%}). The results of this study suggest that levosimendan pretreatment is capable of decreasing infarct size in an ischemia-reperfusion model and improving recovery of cardiac function following ex vivo global ischemia.",
keywords = "Cardiac mechanical activity, Infarct size, Ischemia, Levosimendan, Preconditioning",
author = "I. Lepr{\'a}n and Piero Pollesello and Szilvia Vajda and A. Varr{\'o} and J. Papp",
year = "2006",
month = "10",
doi = "10.1097/01.fjc.0000246151.39758.2a",
language = "English",
volume = "48",
pages = "148--152",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model

AU - Leprán, I.

AU - Pollesello, Piero

AU - Vajda, Szilvia

AU - Varró, A.

AU - Papp, J.

PY - 2006/10

Y1 - 2006/10

N2 - The preconditioning effects of levosimendan were investigated on ischemia-reperfusion induced morphological and functional cardiac damage. Langendorff-perfused rabbit hearts were reserved as controls or subjected either to global myocardial ischemic preconditioning or to perfusion with levosimendan (0.1 μmol/l) for two 5-minute cycles. After a washout period, all hearts were then subjected to 30 minutes of global ischemia and 120 minutes of drug-free reperfusion. Intraventricular pressure and coronary flow were measured, and infarct size determined after nitroblue-tetrazolium staining on completion of the experiments. Levosimendan pretreatment resulted in a significantly smaller elevation from the preischemic level in left ventricular end-diastolic pressure during reperfusion (37 ± 17 mm Hg) compared with controls (56 ± 14 mm Hg) and ischemia-preconditioned hearts (53 ± 34 mm Hg). The left ventricular developed pressure-representing the functional recovery of the heart after ischemia-that was significantly improved by levosimendan pretreatment (38 ± 6% vs 16 ± 5% in controls, P <0.05). In addition, contractility and relaxability parameters (+dP/dt and -dP/dt, respectively) were better preserved in the levosimendan hearts. The volume of infarcted myocardium after global ischemia-reperfusion was significantly (P <0.05) decreased by both ischemic preconditioning (38 ± 2%) or levosimendan pretreatment (45 ± 2%) versus controls (52 ± 2%). The results of this study suggest that levosimendan pretreatment is capable of decreasing infarct size in an ischemia-reperfusion model and improving recovery of cardiac function following ex vivo global ischemia.

AB - The preconditioning effects of levosimendan were investigated on ischemia-reperfusion induced morphological and functional cardiac damage. Langendorff-perfused rabbit hearts were reserved as controls or subjected either to global myocardial ischemic preconditioning or to perfusion with levosimendan (0.1 μmol/l) for two 5-minute cycles. After a washout period, all hearts were then subjected to 30 minutes of global ischemia and 120 minutes of drug-free reperfusion. Intraventricular pressure and coronary flow were measured, and infarct size determined after nitroblue-tetrazolium staining on completion of the experiments. Levosimendan pretreatment resulted in a significantly smaller elevation from the preischemic level in left ventricular end-diastolic pressure during reperfusion (37 ± 17 mm Hg) compared with controls (56 ± 14 mm Hg) and ischemia-preconditioned hearts (53 ± 34 mm Hg). The left ventricular developed pressure-representing the functional recovery of the heart after ischemia-that was significantly improved by levosimendan pretreatment (38 ± 6% vs 16 ± 5% in controls, P <0.05). In addition, contractility and relaxability parameters (+dP/dt and -dP/dt, respectively) were better preserved in the levosimendan hearts. The volume of infarcted myocardium after global ischemia-reperfusion was significantly (P <0.05) decreased by both ischemic preconditioning (38 ± 2%) or levosimendan pretreatment (45 ± 2%) versus controls (52 ± 2%). The results of this study suggest that levosimendan pretreatment is capable of decreasing infarct size in an ischemia-reperfusion model and improving recovery of cardiac function following ex vivo global ischemia.

KW - Cardiac mechanical activity

KW - Infarct size

KW - Ischemia

KW - Levosimendan

KW - Preconditioning

UR - http://www.scopus.com/inward/record.url?scp=33750630750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750630750&partnerID=8YFLogxK

U2 - 10.1097/01.fjc.0000246151.39758.2a

DO - 10.1097/01.fjc.0000246151.39758.2a

M3 - Article

VL - 48

SP - 148

EP - 152

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 4

ER -